UBuyHoldings Inc
UBuyHoldings, Inc. does not have significant operations. It intends to explore and identify business opportunities within the United States and internationally, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company is based in White Plains, New York.
UBuyHoldings Inc (UBYH) - Net Assets
Latest net assets as of November 2025: $-80.78K USD
Based on the latest financial reports, UBuyHoldings Inc (UBYH) has net assets worth $-80.78K USD as of November 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($0.00) and total liabilities ($80.78K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-80.78K |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
UBuyHoldings Inc - Net Assets Trend (2000–2025)
This chart illustrates how UBuyHoldings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for UBuyHoldings Inc (2000–2025)
The table below shows the annual net assets of UBuyHoldings Inc from 2000 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-05-31 | $-52.73K | -251.50% |
| 2024-05-31 | $-15.00K | 0.00% |
| 2023-05-31 | $-15.00K | -- |
| 2022-05-31 | $0.00 | -- |
| 2001-05-31 | $-258.00K | +58.17% |
| 2000-05-31 | $-616.73K | -- |
Equity Component Analysis
This analysis shows how different components contribute to UBuyHoldings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 611992600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (May 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $284.37K | % |
| Other Components | $13.93 Million | % |
| Total Equity | $-52.73K | 100.00% |
UBuyHoldings Inc Competitors by Market Cap
The table below lists competitors of UBuyHoldings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Homasote Co
PINK:HMTC
|
$52.24K |
|
MINT Société anonyme
PA:ALMIN
|
$52.25K |
|
IP Group
LSE:IPO
|
$52.29K |
|
INTESA SANPAOLO - Dusseldorf Stock Exchang
DU:IES
|
$52.32K |
|
Israel China Biotechnology (ICB) Ltd
TA:ICB
|
$52.21K |
|
Hollywood Bowl Group PLC
LSE:BOWL
|
$52.17K |
|
Rank Group PLC
LSE:RNK
|
$52.15K |
|
EQMA3BF
SA:EQMA3BF
|
$52.15K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in UBuyHoldings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -15,000 to -52,725, a change of -37,725.
- Net loss of 52,725 reduced equity.
- Other factors increased equity by 15,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-52.73K | -100.0% |
| Other Changes | $15.00K | +28.45% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares UBuyHoldings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-05-31 | $-0.02 | $0.00 | x |
| 2001-05-31 | $0.00 | $0.00 | x |
| 2022-05-31 | $0.00 | $0.00 | x |
| 2023-05-31 | $0.00 | $0.00 | x |
| 2024-05-31 | $0.00 | $0.00 | x |
| 2025-05-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently UBuyHoldings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 0.00% | -381.20% | 0.18x | 0.00x | $-271.49K |
| 2001 | 0.00% | -17330.92% | 0.00x | 0.00x | $-1.26 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.50K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.50K |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-47.45K |
Industry Comparison
This section compares UBuyHoldings Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| UBuyHoldings Inc (UBYH) | $-80.78K | 0.00% | N/A | $52.23K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |